These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 32677981

  • 1. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan F, Xu Y, Cai Q, Geng R, Chen Q.
    J Exp Clin Cancer Res; 2020 Jul 16; 39(1):137. PubMed ID: 32677981
    [Abstract] [Full Text] [Related]

  • 2. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z, Liu J, Chen H, Zhang Y, Shi H, Huang L, Tao J, Shen R, Wang T.
    Carcinogenesis; 2020 Jun 17; 41(4):467-477. PubMed ID: 31675755
    [Abstract] [Full Text] [Related]

  • 3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C, Feng S, Chen L.
    Mol Cell Biochem; 2021 Feb 17; 476(2):699-713. PubMed ID: 33106913
    [Abstract] [Full Text] [Related]

  • 4. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP3R1/AKT/β-catenin pathway.
    Ding Y, Zhou Y, Li Z, Zhang H, Yang Y, Qin H, Xu Q, Zhao L.
    Life Sci; 2020 Nov 01; 260():118411. PubMed ID: 32918978
    [Abstract] [Full Text] [Related]

  • 5. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G.
    Cancer Lett; 2018 Oct 28; 435():66-79. PubMed ID: 30081068
    [Abstract] [Full Text] [Related]

  • 6. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
    Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY, Xie SD, Qi ST.
    J Neurol Sci; 2016 Aug 15; 367():101-6. PubMed ID: 27423571
    [Abstract] [Full Text] [Related]

  • 7. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z, Wei X, Shen L, Zhu H, Zheng X.
    Cancer Sci; 2019 Jan 15; 110(1):389-400. PubMed ID: 30431207
    [Abstract] [Full Text] [Related]

  • 8. Interferon-γ inducible protein 30 promotes the epithelial-mesenchymal transition-like phenotype and chemoresistance by activating EGFR/AKT/GSK3β/β-catenin pathway in glioma.
    Chen Y, Xu H, Yu P, Wang Q, Li S, Ji F, Wu C, Lan Q.
    CNS Neurosci Ther; 2023 Dec 15; 29(12):4124-4138. PubMed ID: 37408388
    [Abstract] [Full Text] [Related]

  • 9. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
    Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, Chen L, Lyu X, Shi Z, Yan W, You Y.
    Mol Cancer; 2020 Feb 10; 19(1):28. PubMed ID: 32039732
    [Abstract] [Full Text] [Related]

  • 10. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C, Yi X, Chen X, Wu Z, You H, Chen X, Zhang G, Sun Y, Bu X, Wu X, Lin Z, Gu J, Lin Y, Kang D.
    J Exp Clin Cancer Res; 2021 May 11; 40(1):164. PubMed ID: 33975615
    [Abstract] [Full Text] [Related]

  • 11. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
    Bao Z, Chen L, Guo S.
    J Cell Biochem; 2019 Jun 11; 120(6):10205-10214. PubMed ID: 30592329
    [Abstract] [Full Text] [Related]

  • 12. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
    Bian E, Chen X, Xu Y, Ji X, Cheng M, Wang H, Fang Z, Zhao B.
    J Exp Clin Cancer Res; 2019 Aug 20; 38(1):366. PubMed ID: 31429770
    [Abstract] [Full Text] [Related]

  • 13. 11 Long noncoding RNA UCA1 functions as miR-135a sponge to promote the epithelial to mesenchymal transition in glioma.
    Li ZG, Xiang WC, Shui SF, Han XW, Guo D, Yan L.
    J Cell Biochem; 2020 Mar 20; 121(3):2447-2457. PubMed ID: 31680311
    [Abstract] [Full Text] [Related]

  • 14. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q, Guan Y, Li Z, Wang Y, Liu Y, Cui R, Wang Y.
    J Exp Clin Cancer Res; 2019 Aug 16; 38(1):358. PubMed ID: 31419987
    [Abstract] [Full Text] [Related]

  • 15. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH, Yang L, Chen JX, Li QR, Zhu LR, Xu QF, Huang GH, Zhang ZX, Xiang Y, Du L, Zhou Z, Lv SQ.
    Cancer Commun (Lond); 2019 Dec 03; 39(1):81. PubMed ID: 31796105
    [Abstract] [Full Text] [Related]

  • 16. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP, Wang F, Yang M, Wang XY, Jin CL, Ji QK, Li S, Zhao XL.
    J Neurooncol; 2019 Oct 03; 145(1):35-48. PubMed ID: 31502042
    [Abstract] [Full Text] [Related]

  • 17. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q, An W, Sun Y, Qian A, Liu J, Zou D, Yuan Y.
    J Exp Clin Cancer Res; 2020 Sep 07; 39(1):181. PubMed ID: 32894161
    [Abstract] [Full Text] [Related]

  • 18. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
    Chang L, Wang J, Zhou F, Wang D, Chen R, Zhang Y, Zhang J.
    J Neurooncol; 2021 Jan 07; 151(2):157-171. PubMed ID: 33128099
    [Abstract] [Full Text] [Related]

  • 19. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma.
    Liu T, Hu J, Han B, Tan S, Jia W, Xin Y.
    Cell Death Dis; 2021 Oct 16; 12(11):952. PubMed ID: 34657141
    [Abstract] [Full Text] [Related]

  • 20. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J, Ge X, Shi Z, Yu C, Lu C, Wei Y, Zeng A, Wang X, Yan W, Zhang J, You Y.
    Theranostics; 2021 Oct 16; 11(4):1763-1779. PubMed ID: 33408780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.